Schedule Of Interest Expenses |
Total debt consists of the following as of March 31, 2018 and December 31, 2017: ($ in thousands) | | March 31, 2018 | | December 31, 2017 | | Interest rate | | Maturity | | IDB Note | | $ | 14,929 | | $ | 14,929 | | | 2.25 | % | | August - 2020 | | 2017 Subordinated Note Financing | | | 3,254 | | | 3,254 | | | 8.00 | % | | March - 2020 | | 2017 Subordinated Note Financing | | | 13,893 | | | 13,893 | | | 8.00 | % | | May - 2020 | | 2017 Subordinated Note Financing | | | 1,820 | | | 1,820 | | | 8.00 | % | | June - 2020 | | 2017 Subordinated Note Financing | | | 3,018 | | | 3,018 | | | 8.00 | % | | August - 2020 | | 2017 Subordinated Note Financing | | | 6,371 | | | 6,371 | | | 8.00 | % | | September - 2020 | | 2018 Venture Notes | | | 6,517 | | | | | | 8.00 | % | | February 2021 | | 2018 Venture Notes | | | 15,190 | | | | | | 8.00 | % | | March - 2021 | | Opus Credit Facility | | | 9,500 | | | 9,500 | | | 12.00 | % | | September 2019 | | Helocyte Convertible Note, at fair value | | | | | | 1,000 | | | 5.00% - 8.00 | % | | December 2017 | | Helocyte Convertible Note, at fair value | | | 860 | | | 2,194 | | | 5.00% - 8.00 | % | | March - 2018 | | Helocyte Convertible Note, at fair value | | | 945 | | | 1,062 | | | 5.00% - 8.00 | % | | April - 2018 | | Helocyte Convertible Note, at fair value | | | 372 | | | 444 | | | 5.00% - 8.00 | % | | May - 2018 | | Helocyte Convertible Note, at fair value | | | 310 | | | | | | 5.00% - 8-00 | % | | September 2018 | | Helocyte Convertible Note, at fair value | | | 23 | | | | | | 5.00% - 8.00 | % | | November 2018 | | Caelum Convertible Note, at fair value | | | 1,026 | | | 1,017 | | | 8.00 | % | | January - 2019 | | Caelum Convertible Note, at fair value | | | 6,956 | | | 6,900 | | | 8.00 | % | | February - 2019 | | Caelum Convertible Note, at fair value | | | 2,158 | | | 2,142 | | | 8.00 | % | | March - 2019 | | Total notes payable | | | 87,142 | | | 67,544 | | | | | | | | Less: Discount on notes payable | | | 1,047 | | | 1,035 | | | | | | | | Total notes payable | | $ | 86,095 | | $ | 66,509 | | | | | | | |
|
Schedule Of Interest Expenses For Debt Arrangements |
The following table shows the details of interest expense for all debt arrangements during the periods presented. Interest expense includes contractual interest and amortization of the debt discount and amortization of fees represents fees associated with loan transaction costs, amortized over the life of the loan: | | Three Months Ended March 31, | | ($in thousands) | | 2018 | | 2017 | | IDB Note | | | | | | | | Interest | | $ | 84 | | $ | 82 | | Total IDB Note | | | 84 | | | 82 | | NSC Debt | | | | | | | | Interest | | | - | | | 71 | | Amortization of fees | | | - | | | 38 | | Total NSC Debt | | | - | | | 109 | | 2017 Subordinated Note Financing | | | | | | | | Interest | | | 1,048 | | | - | | Amortization of fees | | | 21 | | | - | | Total 2017 Subordinated Note Financing | | | 1,069 | | | - | | Opus Credit Facility | | | | | | | | Interest | | | 281 | | | 232 | | Amortization of fees | | | 319 | | | 208 | | Total Opus Note | | | 600 | | | 440 | | 2018 Venture Notes | | | | | | | | Interest | | | 56 | | | - | | Amortization of fees | | | 1 | | | - | | Total 2018 Venture Notes | | | 57 | | | - | | LOC Fees | | | | | | | | Interest | | | 7 | | | 8 | | Total LOC | | | 7 | | | 8 | | Helocyte Convertible Note | | | | | | | | Interest | | | 68 | | | 54 | | Financing fee | | | - | | | 1 | | Total Helocyte Convertible Note | | | 68 | | | 55 | | Avenue Convertible Note | | | | | | | | Financing fee | | | - | | | 3 | | Total Avenue Convertible Note | | | - | | | 3 | | Caelum Convertible Note | | | | | | | | Interest | | | 196 | | | - | | Total Caelum Convertible Note | | | 196 | | | - | | Other | | | | | | | | Interest | | | 2 | | | 1 | | Total Other | | | 2 | | | 1 | | Total Interest Expense and Financing Fee | | $ | 2,083 | | $ | 698 | |
|